Research News- Oct. 4, 2013

ANNOUNCEMENTS

1. Do you need Microsoft Office?

Your department is no longer charged for Microsoft Office.

Non-Standard Windows Users (PC's without the Partners screensaver):
Submit a ticket to the Partners Help Desk: http://helpdesk.partners.org/computerhd/issues/xnewissue.asp

Mac Users:
Enroll in Partners Enterprise Apple Support (PEAS) and download Office 2011 for Mac. Instructions: http://rc.partners.org/kb/show_article.php?id=294

2. Core of the Week: PET Core

PET Core
Director: Georges El Fakhri, Ph.D.

The PET Core Laboratory provides a full range of technical and professional services for the design and execution of programs using Positron Emission Tomography (PET).

The PET Core Facility provides the required facilities and personnel on a per study basis to allow investigators to use PET without requiring them to acquire the needed special expertise and equipment.

To learn more about the PET Core please click here.

EVENTS

1. Workshop on Study Design: Using MGH Clinical Care Data for Clinical Effectiveness Research

Wednesdays, November 5, 12, 19, December 10* & 17, Simches 3.130, 3:30 - 5:00 pm

Sponsored by the MGH Clinical Research Program

James Meigs, MD, MPH, Director, MGH Clinical Research Program's Clinical Effectiveness Research Unit
Clemens Hong, MD, Instructor in Medicine, HMS, Co-Director, MGH Clinical Research Program's Clinical Effectiveness Research Unit

The Clinical Research Program is offering a five-session seminar series on Clinical Effectiveness Research in the fall of 2013. Throughout these sessions, distinguished faculty will take participants step-by-step through the process of designing an outcomes study using MGH clinical care data.

In parallel to didactic teaching, participants will be expected to develop their own projects, obtain Medical Records IRB approval, submit an RPDR query, and present their work for critical feedback by the end of the course.

Essential curriculum content will include: framing a testable hypothesis, developing a testable hypothesis, using MGH clinical care data, using the Research Patient Data Registry and transforming clinical care data into analytic datasets.

Office hours on Medical Records IRB submission and the RPDR will be offered to assist those who need additional guidance.

Please note that there is a moderate amount of work required outside of the classroom for this course. If you register for this course, please make sure you will be able to devote some time outside of class to complete the assignments.

Enrollment is limited to 20 participants to facilitate interaction and individual attention. Application and approval is required. To ensure placement in the course, early registration is recommended.

*The session on Wednesday, December 10th will be a hands-on computer lab. Each participant must bring a laptop to this session (connected to the Partners network) for an RPDR workshop.

To register for this course and/or view a course outline, click Clinical Effectiveness. Please contact Molly Morrow.

FUNDING OPPORTUNITIES

1. MGH ECOR Deliberative Interim Support Funding

The Executive Committee on Research (ECOR) is now accepting applications for Deliberative Interim Support Funding (ISF). This is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense). Investigators must have applied for independent, long-term support (R01, R21, U01 and P01).

The Deliberative Interim Support process is open to:
1. Investigators whose grants were not scored or whose scores were not transferred into a percentile ranking.
2. Investigators whose grants received scores >20th percentile.
3. Investigators who were awarded Formulaic Bridge Funding (grants with scores < or = 20th percentile), and are now requesting additional financial support (in excess of $75,000 for RO1s, and $37,500 for R21s).
4. A PI who has already received Formulaic Bridge Funding or Deliberative Interim Support on their A0 grant application must apply through the Deliberative Interim Support process for their A1 resubmission regardless of the score they received on their A1.

Application Deadline: Monday, December 2, 2013 - 9:00 PM

Click here for additional information and to apply.
 

2. Sequestration Relief Funding

The Executive Committee on Research (ECOR) is now accepting applications for Sequestration Relief funding. This is open to Investigators that have experienced a funding shortfall as a result of sequestration and do not qualify for either Formulaic Bridge Funding or Deliberative Interim Support.

For eligible applicants:
a. The total funded amount, if awarded, will be sourced 50:50 with the Department. For example, if a PI applies for $100,000, then $50,000 will be sourced from ECOR funds and $50,000 will be sourced from Departmental funds.
. All applications for additional funds must include the Chief's Letter of Support & Cost Sharing Authorization Form for ECOR Funding.

Application Deadline: Monday, December 2, 2013 - 9:00 PM

Click here for additional information and to apply.
 

3. Private Funding Opportunities

Please contact Corporate & Foundation Relations in the Office of Development at devcfr@partners.org if you wish to submit a proposal in response to any of these funding opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.

• National Glaucoma Research (NGR): Standard Awards, BrightFocus Foundation
• Prize in Developmental Biology, March of Dimes Birth Defects Foundation
• Postdoctoral Fellowships for Clinical Neurologists, Parkinson's Disease Foundation (PDF)
• Warren Alpert Foundation Prize
• Career Development Awards, Pancreatic Cancer Action Network
• Springboard Grants, Alex's Lemonade Stand Foundation (ALSF)
• Bridge Grants, Alex's Lemonade Stand Foundation (ALSF)
• Innovation Awards, Alex's Lemonade Stand Foundation (ALSF)
• External Research Awards Program, Focused Ultrasound Surgery Foundation
• Kathryn Barton Hobbs Medical Research Grant, Liam's Land Organization, Inc. (LLO) for Lymphatic Malformation Research
• Meixner Postdoctoral Fellowship in Translational Research, Autism Speaks

Please click here for further details on these funding opportunities.
 

4. NIH Update for Week Ending October 4, 2013

For the latest National Institutes of Health notices, requests for applications, and program announcements, follow this link: http://grants.nih.gov/grants/guide/WeeklyIndex.cfm/10-4-13/

IN CASE YOU MISSED IT

Reminders of recently posted funding opportunities, deadlines and events

NIH Director's Early Independence Awards (DP5)
MGH Letter of Intent Due Date: November 1, 2013
Click here for more information.

National Multiple Sclerosis Society: Health Care Delivery and Policy Research Contracts
Application Deadline: September 30, 2013

MGH Center for the Study of Inflammatory Bowel Disease Pilot/Feasibility Study Grants
Application Deadline: October 15, 2013 - Deadline Extended!

HMS Foundation Funds
Application Deadline: October 16, 2013

2014 Howard M. Goodman Fellowship
Application deadline: Tuesday, October 22, 2013 - Midnight

Bullock-Wellman Postdoctoral Fellowship
Application deadline: November 1, 2013

Charles A. King Trust Postdoctoral Research Fellowship Program
Application deadline: December 16, 2013

IRB Issues for the Bench and Desk Scientist - October 8

Clinical Research Program Spotlight Series: Developing a Peer to Peer Auditing Program - October 9

What Does the IRB Really Want? How to Write a Human Studies Protocol - October 16

Getting Started With REDCap - October 17

Study Electronic Data Capture: REDCap and StudyTRAX - October 23

IRB Hot Topics: IRB Implications of Survey Research - October 23

Save the Date: Research Core Day - December 2